Treatment Resources

Overview

The resources below are provided to health systems, health care providers, and support staff participating in ALZ-NET to ensure the highest level of care is provided to patients living with Alzheimer’s disease and related dementias.

Clinic Note Templates for EMR Documentation

ALZ-NET Sites may use templated clinic notes to streamline ALZ-NET data collection from their Electronic Medical Record (EMR). The following resources are template examples that are structured to align with required data fields collected by ALZ-NET, enabling efficient source documentation and data extraction. Resources have been authorized by Brigham and Women's Hospital, Neurosciences Center for dissemination.

• Initial Evaluation (Version - June 2025)
• Follow up Encounter (Version - June 2025)

Cognitive Assessments

AD8 Screening AssessmentFAQNPI-Q

Functional Activities Questionnaire (FAQ); The Neuropsychiatric Inventory Questionnaire (NPI-Q). ALZ-NET is providing the NPI-Q to you for your clinical use. Any commercial application of the instrument requires separate permission. © J Cummings 1995; all rights reserved.

Novel FDA Approved Therapies for Alzheimer’s Disease

(listed in alphabetical order)

ADUHELM^®  (aducanumab)

Aducanumab was discontinued on Nov. 1, 2024.

• ADUHELM^® (aducanumab) — FDA Label and MedGuide (revised 02/2023)
• ADUHELM^® (aducanumab) — Appropriate Use Recommendations

KISUNLA™ (donanemab)

• KISUNLA™ (donanemab) — FDA Label and MedGuide (revised 07/2024)
  KISUNLA™ (donanemab) — Appropriate Use Recommendations 

LEQEMBI^® (lecanemab)

• LEQEMBI^® (lecanemab) — FDA Label and MedGuide (revised 07/2023)
• LEQEMBI^® (lecanemab) — Appropriate Use Recommendations
• LEQEMBI^® (lecanemab) — Clinician Toolkit

REXULTI™ (brexpiprazole)

• REXULTI™ (brexipiprazole) - FDA Label and MedGuide (revised 05/2024) 

ZUNVEYL (benzgalantamine)

• ZUNVEYL (benzgalantamine) – FDA Label and MedGuide (revised 07/2024)

Alzheimer's Association Education Center

The Alzheimer’s Association Education Center provides free education programs to clinicians providing care to individuals with Alzheimer’s Disease and related dementias. Examples of free programs include Effective Communication Strategies and Dementia Conversations: Driving, Doctor Visits, Legal & Financial Planning.